1 Stock Down 43% to Buy and Hold for 10 Years
The pandemic has receded substantially, and with it, the need for vaccines and medicines against COVID-19. That's not to say we no longer need them -- just a lot less so than we did in the earlier years of the outbreak.
Biotech giant (NASDAQ: MRNA) rose to prominence and made a lot of money thanks to its marketing of one of the leading COVID-19 vaccines, but last year, the company's shares dropped like a rock along with its revenue and earnings. Still, there is a lot to like about Moderna's business.
Let's consider why it might still be worth buying and holding the company's shares for the next decade.
Source Fool.com
Moderna Inc. Stock
€116.14
-0.960%
We see a rather positive sentiment for Moderna Inc. with 16 Buy predictions and 2 Sell predictions.
With a target price of 125 € there is a slightly positive potential of 7.63% for Moderna Inc. compared to the current price of 116.14 €.
